We are live on ! Find out more
GDRX icon

GoodRx Holdings

182 hedge funds and large institutions have $600M invested in GoodRx Holdings in 2025 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 55 increasing their positions, 66 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

188% more call options, than puts

Call options by funds: $4.01M | Put options by funds: $1.4M

57% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 23

25% more funds holding in top 10

Funds holding in top 10: 45 (+1)

12% more capital invested

Capital invested by funds: $537M → $600M (+$63.3M)

7% more funds holding

Funds holding: 170182 (+12)

6.1% more ownership

Funds ownership: 114.11%120.21% (+6.1%)

17% less repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 66

Holders
182
Holders Change
+12
Holders Change %
+7.06%
% of All Funds
2.4%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.07%
New
36
Increased
55
Reduced
66
Closed
23
Calls
$4.01M
Puts
$1.4M
Net Calls
+$2.62M
Net Calls Change
+$652K
Name Holding Trade Value Shares
Change
Change in
Stake
Point72 Asset Management
26
Point72 Asset Management
Connecticut
$2.52M +$294K +67,643 +15%
Jane Street
27
Jane Street
New York
$2.43M +$1.75M +403,981 +481%
Bank of America
28
Bank of America
North Carolina
$2.23M +$517K +119,084 +36%
Morgan Stanley
29
Morgan Stanley
New York
$2.15M -$1.29M -297,761 -41%
Northern Trust
30
Northern Trust
Illinois
$2.01M -$38.7K -8,903 -2%
LSV Asset Management
31
LSV Asset Management
Illinois
$1.9M +$1.66M +381,564 New
PP
32
PDT Partners
New York
$1.71M -$114K -26,277 -7%
JP Morgan Chase
33
JP Morgan Chase
New York
$1.63M +$1.4M +322,115 +6,735%
Goldman Sachs
34
Goldman Sachs
New York
$1.44M -$2.14M -493,338 -63%
UBS Group
35
UBS Group
Switzerland
$1.37M -$714K -164,437 -37%
XT
36
XTX Topco
Cayman Islands
$1.36M +$872K +200,852 +281%
Assenagon Asset Management
37
Assenagon Asset Management
Luxembourg
$1.28M -$457K -105,133 -29%
T. Rowe Price Associates
38
T. Rowe Price Associates
Maryland
$1.28M +$13.6K +3,140 +1%
TAM
39
Tocqueville Asset Management
New York
$1.25M -$347K -80,000 -24%
EGM
40
Engineers Gate Manager
New York
$1.23M +$102K +23,571 +11%
Balyasny Asset Management
41
Balyasny Asset Management
Illinois
$1.23M -$7.14K -1,644 -0.7%
Allianz Asset Management
42
Allianz Asset Management
Germany
$1.18M -$182K -42,000 -15%
AG
43
Algert Global
California
$1.15M -$199K -45,880 -17%
UBS AM
44
UBS AM
Illinois
$1.13M +$374K +86,023 +61%
BNP Paribas Financial Markets
45
BNP Paribas Financial Markets
France
$1.11M +$227K +52,289 +31%
VRS
46
Virginia Retirement Systems
Virginia
$981K +$316K +72,800 +59%
Mackenzie Financial
47
Mackenzie Financial
Ontario, Canada
$917K +$799K +184,047 New
CSS
48
Cubist Systematic Strategies
Connecticut
$895K -$851K -195,989 -52%
AQR Capital Management
49
AQR Capital Management
Connecticut
$892K -$448K -103,219 -37%
Verition Fund Management
50
Verition Fund Management
Connecticut
$891K +$163K +37,535 +27%

GDRX Hedge Fund Activity: Q2 2025 in Review

182 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in GoodRx Holdings (GDRX) for Q2 2025, worth a combined $600M — up 12% from $537M a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new GDRX positions and 23 closed out — a net gain of 13 holders — while 55 added to existing stakes and 66 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $3.8M. The largest seller was 8 Knots Management, exiting entirely with an estimated $8.11M sold.

  • 182 institutional investors held GoodRx Holdings (GDRX) as of Q2 2025, up from 170 in Q1 2025.
  • Funds reported $600M of GoodRx Holdings stock for Q2 2025, up 12% quarter-over-quarter.
  • 36 funds opened new GoodRx Holdings positions in Q2 2025 and 23 closed out, a net change of +13 holders.
  • The largest GoodRx Holdings buyer in Q2 2025 was Citadel Advisors, an estimated $3.8M added.
  • The largest GoodRx Holdings seller in Q2 2025 was 8 Knots Management, an estimated $8.11M sold.

Based on aggregated 13F filings for Q2 2025.